Clinical Trial Update: Gentuximab Combined With Paclitaxel Compared With Placebo Combined With Paclitaxel for Gastric Adenocarcinoma. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating gentuximab plus paclitaxel versus placebo plus paclitaxel in gastric adenocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma

Drugs mentioned

• Gentuximab (gentuximab)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Adenocarcinoma of Stomach | Phase 3 | Status: UNKNOWN